Future profiling of BFCNs localized to the nucleus basalis of Meynert, which display a tau pathology in prodromal and early AD [98,99,100,101], are essential to examine basocortical circuit alterations in response to MCS. This evidence concerns the gene MAPT and Alzheimer disease.